Int J Radiat Oncol Biol Phys
BilirubinCarcinoma, HepatocellularContrast Media
Dr. Kyle Clifford Cuneo, MD
NPI1740464627PAC ID3577712389
- Medicare services, 2024
- 1,040
- Medicare patients, 2024
- 123
- Part D claims, 2024
- 13
- Publications
- 77
- Clinical trials
- 5
- Practice address
- 1500 E Medical Center Dr, Ann Arbor, MI 48109
- Practice phone
- Call (734) 936-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
University Hospital
School-Based Health Center · Ann Arbor, Michigan
Find Dr. Cuneo's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kyle Clifford Cuneo is a radiation oncologist in Ann Arbor, Michigan
Dr. Cuneo practices at University Hospital in Ann Arbor, Michigan.
Dr. Cuneo's NPI, 1740464627, was assigned on December 27, 2007. Dr. Cuneo graduated from Vanderbilt University School of Medicine in 2007. Dr. Cuneo holds Michigan license 4301100272.
NPI and contact details
- NPI
- 1740464627NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3577712389
- NPI enumeration date
- December 27, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (734) 936-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 45
- Medical school graduation
- 2007
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Kyle Clifford Cuneo practices at University Hospital in Ann Arbor, Michigan
Dr. Cuneo's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.
- University Hospital1500 E Medical Center Dr, Ann Arbor, MI 48109Phone(734) 936-4000
Source: Dmand AI Affiliation Data
Dr. Kyle Clifford Cuneo is affiliated with 3 sites of care and 4 medical groups
Dr. Cuneo's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Cuneo is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dmand AI also links Dr. Cuneo to 1 more hospital and 3 medical groups, each named with a free account. Dr. Cuneo's employer is on file too: a school & student health.
University HospitalPrimary
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Kyle Clifford Cuneo's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cuneo practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| University Hospital | Available with a free account |
| +2 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Cuneo practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kyle Clifford Cuneo is one of 200 radiation oncologists in Michigan
Radiation oncology is Dr. Cuneo's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Cuneo's licenses on file in 2 states: Michigan and Tennessee.
Specialties and state licenses
- Radiation oncology, MichiganPrimary
- Therapeutic radiology, Tennessee
Radiation oncologists near Dr. Cuneo
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kyle Clifford Cuneo billed Medicare for 1,040 services in 2024
CMS data shows 1,040 Medicare services from Dr. Cuneo across 18 procedure codes in 2024, for 123 Medicare patients. Medicare paid $82,802 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 20241,040
Medicare patients123
Paid by Medicare$82,802
Procedure codes18
Dr. Cuneo's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 1,1062024: 82026%
- Other services
- 2023: 02024: 149
- Office and hospital visits
- 2023: 632024: 7113%
Dr. Cuneo compared with the Michigan median for radiation oncologists, 2024
- Dr. Cuneo
- Michigan median
- Medicare services
- 1,040vs 1,1489% below
- Medicare patients
- 123vs 1338% below
- Part D claims
- 12vs 3868% below
Medians across 184 radiation oncologists in Michigan with Dmand AI profiles that report each measure.
Dr. Cuneo's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Cuneo?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Cuneo and other radiation oncologists in Michigan.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Kyle Clifford Cuneo treated 123 Medicare patients in 2024, average age 73
CMS counts 123 Medicare patients who saw Dr. Cuneo in 2024. The largest group is 65 to 74, with 64 patients. 72% of them have high blood pressure, and 59% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Cuneo's median patient age at 65, with 45% women.
Medicare patients, 2024123
Average age73
Average risk score2.58
Also on Medicaid15%
Dr. Cuneo's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Cuneo's Medicare patients by sex, 2024
- Women5343%
- Men7057%
Chronic conditions among Dr. Cuneo's Medicare patients, 2024
- High blood pressure72%
- High cholesterol59%
- Cancer37%
- Arthritis33%
- Chronic kidney disease33%
- Diabetes33%
- Anxiety28%
- Mood disorders28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Cuneo's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 65
Patient panel by sex, all payers
- Women45%
- Men55%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Kyle Clifford Cuneo wrote 13 Medicare Part D claims in 2024
In 2024, Dr. Cuneo wrote 13 Medicare Part D claims for 11 patients. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $235 in total drug cost.
Part D claims, 202413
Drugs named by CMS1
Total drug cost$235
Part D patients11
Dr. Cuneo's most prescribed drugs by claims, 2017
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Kyle Clifford Cuneo offers telehealth to Medicare patients
Dr. Cuneo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cuneo as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find radiation oncologists like Dr. Cuneo by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Kyle Clifford Cuneo has 77 publications on record
Dmand AI links 77 papers to Dr. Cuneo, published from 2010 to 2025. 2017 was the busiest year, with 8. The most frequent topics are Liver Neoplasms, Carcinoma, Hepatocellular and Radiosurgery. Dr. Cuneo has published most often in Int J Radiat Oncol Biol Phys. Dr. Cuneo's most frequent co-authors are Dawn Owen, MD, Joseph Robert Evans, MD, PhD and Mary Uan-Sian Feng, MD.
Papers77
Years published2010 to 2025
Dr. Cuneo's papers by year, 2016 to 2025
Topics Dr. Cuneo writes about most
- Liver Neoplasms
- Carcinoma, Hepatocellular
- Radiosurgery
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Magnetic Resonance Imaging
- Pancreatic Neoplasms
- Radiotherapy Dosage
Dr. Cuneo's most frequent co-authors
- Dawn Owen, MD19 shared papers
- Joseph Robert Evans, MD, PhD11 shared papers
- Mary Uan-Sian Feng, MD9 shared papers
Recent publications by Dr. Cuneo
Int J Radiat Oncol Biol Phys
Health PhysicsMichiganRadiation Oncology
Artificial IntelligenceCarcinoma, HepatocellularCarcinoma, Non-Small-Cell Lung
AmmoniaCarcinoma, HepatocellularCell Line, Tumor
See who Dr. Cuneo researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Cuneo works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kyle Clifford Cuneo has worked on 5 clinical trials
Dmand AI links Dr. Cuneo to 5 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Liver Neoplasms, Anal Canal Carcinoma and Carcinoma, Hepatocellular. University of Michigan Rogel Cancer Center sponsors the most, 2.
Conditions in Dr. Cuneo's trials
- Liver Neoplasms
- Anal Canal Carcinoma
- Carcinoma, Hepatocellular
- Rectal Neoplasms
- Anus Neoplasms
Investigators on the most trials with Dr. Cuneo
- Mary Uan-Sian Feng, MD3 shared trials
- Michael F. Bassetti2 shared trials
- Leander Cannick, MD2 shared trials
Recent clinical trials with Dr. Cuneo
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE) (opens in a new tab)
Active, not recruitingPhase 2
Anal Canal CarcinomaAnus NeoplasmsCapecitabineFluorouracilMitomycin
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer (opens in a new tab)
CompletedPhase 2
Rectal NeoplasmsRectal DiseasesPembrolizumabVeliparibCapecitabine
Carcinoma, HepatocellularLiver NeoplasmsAdaptive Radiation Therapy
Liver NeoplasmsLiver Diseases
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kyle Clifford Cuneo graduated from Vanderbilt University School of Medicine
Dr. Cuneo graduated from Vanderbilt University School of Medicine in 2007.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Kyle Clifford Cuneo's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kyle Clifford Cuneo
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kyle Clifford Cuneo's NPI number?
Dr. Kyle Clifford Cuneo's NPI number is 1740464627. It was assigned on December 27, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Kyle Clifford Cuneo?
Dr. Kyle Clifford Cuneo is a radiation oncologist in Ann Arbor, Michigan. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Kyle Clifford Cuneo practice?
Dr. Cuneo practices at 1500 E Medical Center Dr, Ann Arbor, MI 48109. Dr. Cuneo's primary practice is University Hospital in Ann Arbor, Michigan. Dmand AI also links Dr. Cuneo to 1 hospital and 3 medical groups.
What is Dr. Kyle Clifford Cuneo's office phone number?
The practice phone on file for Dr. Cuneo is (734) 936-4000.
What is Dr. Kyle Clifford Cuneo's medical license number?
Dr. Cuneo holds Michigan license 4301100272, one of the licenses on file in 2 states.
Which states has Dr. Kyle Clifford Cuneo been licensed in?
Dmand AI has state licenses on file for Dr. Cuneo in Michigan and Tennessee.
Which hospitals is Dr. Kyle Clifford Cuneo affiliated with?
Dr. Cuneo is affiliated with University Hospital. Dmand AI links Dr. Cuneo to 1 more hospital.
What medical group is Dr. Kyle Clifford Cuneo part of?
Dr. Cuneo is linked to University of Michigan Health. Dmand AI links Dr. Cuneo to 3 more medical groups.
Does Dr. Kyle Clifford Cuneo accept Medicare?
Yes. CMS data shows Dr. Cuneo billed Medicare for 1,040 services in 2024, and Dr. Cuneo accepts Medicare assignment.
Does Dr. Kyle Clifford Cuneo offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Cuneo as offering telehealth services.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Kyle Clifford Cuneo see?
CMS counts 123 Medicare patients who saw Dr. Cuneo in 2024, with an average age of 73.
What services does Dr. Kyle Clifford Cuneo bill to Medicare?
In 2024, Dr. Cuneo's most billed Medicare services were radiation oncology (77014), medicare service (G6002) and radiation oncology (77334).
Where did Dr. Kyle Clifford Cuneo go to medical school?
Dr. Cuneo graduated from Vanderbilt University School of Medicine in 2007.
What drugs does Dr. Kyle Clifford Cuneo prescribe most?
In 2017 Medicare Part D data, Dr. Cuneo's most prescribed drugs by claims were Ondansetron HCl.
How long has Dr. Kyle Clifford Cuneo been practicing?
Dr. Cuneo graduated from medical school in 2007, 19 years ago.
Does Dr. Kyle Clifford Cuneo do research?
Dmand AI links 77 publications to Dr. Cuneo, published from 2010 to 2025. Dr. Cuneo has worked on 5 clinical trials.
Who does Dr. Kyle Clifford Cuneo publish with?
Dr. Cuneo's most frequent co-authors are Dawn Owen, MD (19 shared papers), Joseph Robert Evans, MD, PhD (11 shared papers) and Mary Uan-Sian Feng, MD (9 shared papers).
Selling to radiation oncology practices?
See radiation oncologists in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card